---  
layout: startup_page  
title: "Ypsilon Therapeutics"  
id: "ypsilontx.com"  
permalink: "/ypsilontherapeuticsypsilontx.com01302025/"  
website: "https://ypsilontx.com/"  
funding_round: "Seed"  
funding_amount: "$2.7M"  
investors: "Cancer Prevention & Research Institute of Texas (CPRIT), 82VS, Alloy Therapeutics"  
about: "Ypsilon Therapeutics is developing next-generation T-cell receptor mimic (TCRm) antibodies to treat difficult-to-treat solid tumors. Their lead program focuses on highly specific targeting of cancer cells using bispecific T cell engager molecules. This approach offers a novel method for precise and effective cancer treatment."  
markets: "Biotechnology, Oncology, Immunotherapy, Health Care, Medical, Therapeutics"  
hq: "Waltham, Massachusetts, United States"  
founded_year: ""  
linkedin: "https://www.linkedin.com/company/ypsilontx"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/ypsilon-therapeutics"  
pitchbook: ""  

date_display: "30-Jan-2025"  
date: "2025-01-30"

# SEO Optimization  
meta_title: "Ypsilon Therapeutics - Seed Funding ($2.7M)"  
meta_description: "Ypsilon Therapeutics, Ypsilon Therapeutics is developing next-generation T-cell receptor mimic (TCRm) antibodies to treat difficult-to-treat solid tumors. Their lead progra..."  
meta_keywords: "Ypsilon Therapeutics, Biotechnology, Oncology, Immunotherapy, Health Care, Medical, Therapeutics, Seed funding"  
canonical_url: "https://startup.projectstartups.com/ypsilontherapeuticsypsilontx.com01302025/"  
---